TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7049588

Group type: EXPERIMENTAL
Intervention: Proglumetacin (300 mg daily in two divided doses)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naproxen (500 mg daily in two divided doses)
Number of subjects: 40
Study: 31563536

Group type: EXPERIMENTAL
Intervention: Robot-assisted sacrocolpopexy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic sacrocolpopexy
Number of subjects: 100
Study: 29470389

Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet (43 g/day)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control diet (nut-free diet)
Number of subjects: 194
Study: 27246468

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (AA)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHP)
Number of subjects: 609
Study: 25339455

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 200
Study: 22678562

Group type: EXPERIMENTAL
Intervention: Low glycaemic load diet
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group diet
Number of subjects: 32
Study: 19924114

Group type: EXPERIMENTAL
Intervention: Delta‐9‐THC
Number of subjects: 15

Group type: COMPARATOR
Intervention: CBD
Number of subjects: 15
Study: 18188658

Group type: EXPERIMENTAL
Intervention: Exercise group (two one-hour exercise sessions per week for 20 weeks with a trained physiotherapist)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (receiving no intervention)
Number of subjects: 98
Study: 16025052

Group type: EXPERIMENTAL
Intervention: Evac tonsillectomy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Bovie tonsillectomy
Number of subjects: 17
Study: 12436013

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Psychoeducational Therapy (PET)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both CBT and PET
Number of subjects: 88
Study: 12029990

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 5640

Group type: COMPARATOR
Intervention: Pravastatin (low dose, 5 mg/day)
Number of subjects: 5640

Group type: EXPERIMENTAL
Intervention: Simvastatin (5 to 10 mg/day for 6 years)
Number of subjects: 5640
Study: 9857636

Group type: EXPERIMENTAL
Intervention: Radiotherapy (6 x 2 Gy using 6 MV photons)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study: 8934955

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5% lidocaine
Number of subjects: 0
Study: 2693916

Group type: EXPERIMENTAL
Intervention: Oestrogen-progestogen replacement therapy for 12 months
Number of subjects: 57

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 57
Study: 447801

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (100 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (400 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 6
Study: 31591706

Group type: COMPARATOR
Intervention: Single injection of PPD (n=29)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Multiple injections of PPD (n=29)
Number of subjects: 66
Study: 28097515

Group type: EXPERIMENTAL
Intervention: Early palliative care
Number of subjects: 350
Study: 25713937

Group type: EXPERIMENTAL
Intervention: Rule 4901 (residential wood-burning regulation)
Number of subjects: 2
Study: 23799166

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Electrocautery tonsillectomy
Number of subjects: 80
Study: 21849730

Group type: EXPERIMENTAL
Intervention: Multimodal work hardening (MWH)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Conventional musculoskeletal rehabilitation (controls)
Number of subjects: 236
Study: 19487505

Group type: EXPERIMENTAL
Intervention: Surgical treatment (standard decompressive laminectomy with or without fusion)
Number of subjects: 607

Group type: COMPARATOR
Intervention: Nonoperative care
Number of subjects: 607
Study: 17925539

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (n = 19,541), goal to reduce total fat intake to 20% of energy and increase consumption of vegetables, fruits, and grains.
Number of subjects: 48835

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (n = 19,541)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Comparison group (usual diet; n = 29,294)
Number of subjects: 48835
Study: 15482766

Group type: EXPERIMENTAL
Intervention: Transdermal E(2) 50 microg/24 hours
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Transdermal E(2) 75 microg/24 hours
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Transdermal E(2) 100 microg/24 hours
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11172837

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 35
Study: 9155575

Group type: EXPERIMENTAL
Intervention: Alcoholic beverages produced by fermentation (beer, wine, champagne, martini, sherry)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Distilled alcoholic beverages (whisky, cognac, calvados, armagnac, rum)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Distilled remaining parts of beer, wine, and sherry
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (isotonic glucose and distilled water)
Number of subjects: 16
Study: 7815840

Group type: EXPERIMENTAL
Intervention: ATRA (all-trans retinoic acid) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maintenance therapy
Number of subjects: 0
Study: 2455141

Group type: EXPERIMENTAL
Intervention: Nifedipine as a capsule with high sodium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine as a tablet with high sodium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine with addition of a thiazide diuretic for 1 month
Number of subjects: 0
Study: 29866147

Group type: EXPERIMENTAL
Intervention: Actitan F and standard oral rehydration (SOR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard oral rehydration (SOR) only
Number of subjects: 60
Study: 26518698

Group type: EXPERIMENTAL
Intervention: Active CPAP
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Belief in receiving active CPAP
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Presence of cardiovascular disorders
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Presence of anxiety
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Presence of nasal congestion
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Adherence during the week prior to a clinic visit
Number of subjects: 1105
Study: 24781035

Group type: COMPARATOR
Intervention: Standard Management (SM)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Sulodexide
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 167
Study: 22561556

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri NCIMB 30242 capsules (n=67)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo capsules (n=64)
Number of subjects: 131
Study: 20054544

Group type: EXPERIMENTAL
Intervention: Paracetamol (1 g as a 100 ml solution infused over 15 min, 1 h before anesthesia induction and then at 6-h intervals for 24 h)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Paracetamol and Placebo
Number of subjects: 124
Study: 18403876

Group type: EXPERIMENTAL
Intervention: Softliner material
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Soft lining materials
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Time periods (days 1, 7, and 14)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Acrylic resin
Number of subjects: 17
Study: 15784021

Group type: EXPERIMENTAL
Intervention: EVL plus propranolol
Number of subjects: 144

Group type: COMPARATOR
Intervention: EVL alone
Number of subjects: 144
Study: 15656359

Group type: EXPERIMENTAL
Intervention: PPCIOL
Number of subjects: 43

Group type: COMPARATOR
Intervention: Lasik
Number of subjects: 43
Study: 11004028

Group type: EXPERIMENTAL
Intervention: Clonidine (2.25 ng/mL) in awake subjects
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Clonidine (2.25 ng/mL) in anesthetized subjects
Number of subjects: 7
Study: 8630718

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 1609533

Group type: EXPERIMENTAL
Intervention: 100 mg Tramadol (Tramal)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 100 mg Tramadol (Tramal) and 10 mg Triflupromazine (Psyquil)
Number of subjects: 66

Group type: COMPARATOR
Intervention: 50 mg Pethidine (Alodan) and 10 mg Triflupromazine (Psyquil)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combination of analgesic with antiemetic
Number of subjects: 66
Study: 6375285

Group type: EXPERIMENTAL
Intervention: Oral pretreatment with verapamil for one week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-hour iv infusion of verapamil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral glibenclamide therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: iv infusion of verapamil
Number of subjects: 0
Study: 3550149

Group type: EXPERIMENTAL
Intervention: Intracavernous self-injection of phentolamine and papaverine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30
Study: 30882529

Group type: EXPERIMENTAL
Intervention: Lower-level cognitive tasks (serial subtract 3)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Higher-level cognitive tasks (serial subtract 7)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Rapid visual input processing primary reaction time
Number of subjects: 11
Study: 28720080

Group type: EXPERIMENTAL
Intervention: Mailed nicotine replacement therapy (NRT; nicotine patch) for 5 weeks
Number of subjects: 924

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 924
Study: 26325640

Group type: EXPERIMENTAL
Intervention: Hydralazine HCl
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 50
Study: 23635012

Group type: EXPERIMENTAL
Intervention: Reduction of dialysate sodium concentration from 138 to 135 mEq/L (Group A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No reduction of dialysate sodium concentration (Group B)
Number of subjects: 52
Study: 20708269

Group type: EXPERIMENTAL
Intervention: Intravitreal clindamycin and dexamethasone (IVCD)
Number of subjects: 68
Study: 18482012

Group type: EXPERIMENTAL
Intervention: Onion extract gel treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 60
Study: 17058225

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 10 mg daily
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) 300 mg daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: Both ADV and TDF
Number of subjects: 52
Study: 12221213

Group type: EXPERIMENTAL
Intervention: Enzymatically hydrolyzed isoflavone drink (1 mg total isoflavones/kg body)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non-hydrolyzed isoflavone drink (1 mg total isoflavones/kg body)
Number of subjects: 6
Study: 9475650

Group type: EXPERIMENTAL
Intervention: Wet Suit (WS)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Swimming Suit (SS)
Number of subjects: 5
Study: 7620688

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin 5 mg/24 hours for 2 weeks, titrated to 10 mg/24 hours for 4 weeks if needed
Number of subjects: 2456

Group type: EXPERIMENTAL
Intervention: Oral nitrates (previous treatment)
Number of subjects: 2456

Group type: COMPARATOR
Intervention: Control group (previous treatment with oral nitrates)
Number of subjects: 2456
Study: 2239903

Group type: EXPERIMENTAL
Intervention: Walking group
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Walking group and Control group combined
Number of subjects: 176
Study: 364393

Group type: EXPERIMENTAL
Intervention: Furosemide (2 mg/kg intravenously)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5% dextrose water in 0.225% sodium chloride (control group)
Number of subjects: 12
Study: 31537171

Group type: EXPERIMENTAL
Intervention: Attention Network Test (ANT) under symptom provocation conditions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-clinical controls
Number of subjects: 22
Study: 28616772

Group type: EXPERIMENTAL
Intervention: Smoke_less (CBT program: four weekly group sessions and two telephone calls over 5 weeks, n = 51)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Active comparator (one 15-minute counseling session, n = 49)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Waiting control group (no intervention during the study, n = 55)
Number of subjects: 155
Study: 27899150

Group type: EXPERIMENTAL
Intervention: Trials reporting treatment effect estimate and/or p-value
Number of subjects: 2823

Group type: COMPARATOR
Intervention: Trials with no treatment effect estimate or p-value posted
Number of subjects: 2823
Study: 24528600

Group type: EXPERIMENTAL
Intervention: 12-week physical and leisure activity programme
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study: 22633344

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 105

Group type: COMPARATOR
Intervention: Patching
Number of subjects: 105
Study: 20729619

Group type: EXPERIMENTAL
Intervention: Add on ADV to ongoing LAM (Group 2)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Add on LAM to ADV monotherapy (Group 3)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Switch to ADV monotherapy (Group 1)
Number of subjects: 99
Study: 17708584

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 939

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 939
Study: 17039651

Group type: EXPERIMENTAL
Intervention: Zostavax vaccine
Number of subjects: 38546
Study: 15344896

Group type: EXPERIMENTAL
Intervention: Management of intracranial hemorrhage resulting from bleeding disorders
Number of subjects: 0
Study: 10476589

Group type: EXPERIMENTAL
Intervention: abciximab (bolus and 12 hour infusion) with weight-adjusted low-dose heparin
Number of subjects: 106

Group type: COMPARATOR
Intervention: Weight-adjusted heparin alone
Number of subjects: 106
Study: 8758450

Group type: EXPERIMENTAL
Intervention: Scopolamine detoxification (10 days program)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Methadone detoxification (10 days program)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clonidine treatment (10 days program)
Number of subjects: 100
Study: 1951162

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (WHO recommended dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6112411

Group type: EXPERIMENTAL
Intervention: Intra-articular orgotein (4 mg/week for 6 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intra-articular aspirin (4 mg/week for 6 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intra-articular orgotein
Number of subjects: 30
Study: 31397768

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Adherent exercisers
Number of subjects: 160

Group type: COMPARATOR
Intervention: Nonadherent exercisers
Number of subjects: 160
Study: 15887359

Group type: EXPERIMENTAL
Intervention: Computer-based training (CB)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Instructor-led training (IL)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study: 29454587

Group type: EXPERIMENTAL
Intervention: EGFR mutations
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: KRAS mutations
Number of subjects: 313

Group type: COMPARATOR
Intervention: Control group (no mutations)
Number of subjects: 313
Study: 26983794

Group type: EXPERIMENTAL
Intervention: Perioperative educational program (monitoring of arm dysfunction, exercises, massage, and lifestyle adjustments) over 12 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group received written information about shoulder exercise before surgery
Number of subjects: 64
Study: 24134405

Group type: EXPERIMENTAL
Intervention: Single subcutaneous 1500 U/kg rEPO at day-1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hypothermia for 72 hours
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Supportive care
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: rEPO
Number of subjects: 45
Study: 22240377

Group type: EXPERIMENTAL
Intervention: Group 1: 2 × 60 min·wk(‐1) treadmill walking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group 2: 4 × 30 min·wk(‐1) treadmill walking
Number of subjects: 0
Study: 20190068

Group type: EXPERIMENTAL
Intervention: Health Topics Overview (HTO) available without direct links to answers
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Health Topics Overview (HTO) available with direct links to answers
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Health Topics Overview (HTO) not available
Number of subjects: 48

Group type: COMPARATOR
Intervention: Health Topics Overview (HTO) available
Number of subjects: 48
Study: 18416955

Group type: EXPERIMENTAL
Intervention: Adjunct research project (Tromsø Mammography and Breast Cancer study)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Control arm (no adjunct research project)
Number of subjects: 650
Study: 15824048

Group type: EXPERIMENTAL
Intervention: Dysport 350 U
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dysport 500 U
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dysport 1000 U
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 12422330

Group type: EXPERIMENTAL
Intervention: 3-point bending lumbar extension traction, provided in-office 3 to 4 times a week for 12+/−4 weeks; traction duration started at 3 minutes and increased to a maximum of 20 minutes.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3-point bending lumbar extension traction
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 48
Study: 10815082

Group type: EXPERIMENTAL
Intervention: ancrod
Number of subjects: 500

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 500
Study: 8992090

Group type: EXPERIMENTAL
Intervention: Laser flare meter FM‐500 (Kowa, diode laser, 670 nm)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Laser flare-cell meter FC‐1000 (Kowa, He‐Ne laser, 632.8 nm)
Number of subjects: 31
Study: 1670591

Group type: EXPERIMENTAL
Intervention: Dideoxyinosine (ddl) administered orally in three divided doses totaling 60, 120, 180, 360, or 540 mg per square meter of body-surface area per day for 24 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Dideoxyinosine (ddl) administered orally
Number of subjects: 43
Study: 6606153

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Neuroticism
Number of subjects: 30
Study: 30898654

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB) training with motor imagery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham feedback (Control)
Number of subjects: 0
Study: 28019071

Group type: EXPERIMENTAL
Intervention: atrasentan 0.75 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: atrasentan 1.25 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 27071986

Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both Fidaxomicin and Vancomycin
Number of subjects: 34
Study: 24612248

Group type: EXPERIMENTAL
Intervention: Lycopene-enriched virgin olive oil (300 ppm) (1.5 mL three times a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (1.5 mL three times a day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lycopene-enriched virgin olive oil (300 ppm)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 21993020

Group type: EXPERIMENTAL
Intervention: Morning Training Group (MTG, 07:00-08:00 hours, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Evening Training Group (ETG, 17:00-18:00 hours, n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG, n = 10)
Number of subjects: 30
Study: 20380653

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg qd
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 18166880

Group type: EXPERIMENTAL
Intervention: Conventional strategy (systematic mailing of the test kit to all non-responders)
Number of subjects: 10930

Group type: COMPARATOR
Intervention: Experimental strategy (mailing the test kit only to non-responders who requested it after receiving a recall letter)
Number of subjects: 10930

Group type: EXPERIMENTAL
Intervention: Conventional strategy
Number of subjects: 10930

Group type: COMPARATOR
Intervention: Experimental strategy
Number of subjects: 10930
Study: 15643227

Group type: EXPERIMENTAL
Intervention: Darifenacin controlled release (3.75 mg once daily)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Darifenacin controlled release (7.5 mg once daily)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Darifenacin controlled release (15 mg once daily)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Darifenacin immediate-release (5 mg 3 times daily)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 12297120

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (Caelyx)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan
Number of subjects: 474